Effects of Bromocriptine and Terguride on Cell Proliferation and Apoptosis in the Estrogen-stimulated Anterior Pituitary Gland of the Rat

Neurologia medico-chirurgica

Volumn 37, Issue 12, 1997, Pages 901-906

  Yonezawa, Kazuki ^a   Tamaki, Norihiko ^a   Kokunai, Takashi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

apoptosis; bromocriptine; prolactinoma; proliferative rate; terguride

Indexed keywords

BROMOCRIPTINE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; TERGURIDE;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA NICK TRANSLATION; DRUG EFFECT; HORMONAL REGULATION; LABELING INDEX; NONHUMAN; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RAT;

ANIMALS; APOPTOSIS; BROMOCRIPTINE; CELL DIVISION; CELL MIGRATION INHIBITION; DOPAMINE AGONISTS; ESTRADIOL; FEMALE; HORMONE ANTAGONISTS; LISURIDE; NEOPLASM CIRCULATING CELLS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTINOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR;

EID: 0031455454     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.37.901     Document Type: Article

References (40)

1. Aellig WH, Nüesch E: Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration in man. Int J Clin Pharmacol 15: 106-112, 1977.
2. Baker BL, Everett NB: The effect of small dose of diethylstilbestrol on the anterior hypophysis of the immature rat. J Endocrinol 34: 254-264, 1944.
3. Banerjee SK, De A, Sarkar DK: Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Lett 87: 139-144, 1994.
4. Bjorklund A, Falck BC: Histochemical characterization of a tryptamine-like substance stored in cells of the mammalian adenohypophysis. Acta Physiol Scand 77: 475-489, 1969.
5. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-d. Nature 326: 515-517, 1987.
6. Brue T, Pellegrini I, Gunz G, Morange I, Dewalliy D, Brownell J, Enjalbert A, Jaquet P: Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine. J Clin Endocrinol Metab 74:577-584, 1992.
7. Brue T, Pellegrini I, Priou A: Prolactinomas and resistance to dopamine agonists. Horm Res 38: 78-83, 1992.
8. Chiodini PG, Liuzzi A, Cozzi R, Verde G, Oppizzi G, Dallabonzana D, Speita B, Silvestrini F, Borghi G, Luccarelli G, Rainer E, Horowski R: Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. J Clin Endocrinol 53: 737-743, 1981.
9. Collip JB, Selye H, Thomson DL: Histological changes in the hypophysis produced by chronic administration of hypophyseal extracts. Proc Soc Exp Biol Med 31: 682-683, 1933.
10. Dall'Ara A, Lima L, Cocchi D, Di Salle E, Cancio E, Devesa J, Miiller EE: Inhibitiory effect of cabergoline on the development of estrogen-induced prolactin secreting adenomas of the pituitary. Eur J Pharmacol 151:97-102, 1988.
11. Davies C, Jacobi J, Lloyd HM, Meares JD: DNA synthesis and the secretion of prolactin and growth hormone by pituitary gland of the male rat: Effects of diethylstilbestrol and 2-bromo-α-ergocryptine methanesulfonate. J Endocrinol 61: 411-417, 1974.
12. Drewett N, Jacobi JM, Willgoss DA, Lloyd HM: Apoptosis in the anterior pituitary gland of the rats: Studies with estrogen and bromocriptine. Neuroendocrinology 57: 89-95, 1993.
13. Duranteau L, Chanson P, Lavoinne A, Horlait S, Lubetzki J, Kuhn JM: Effect of a new dopaminergic agonist CV205-502 on plasma prolactin levels and tumor size in bromocriptine resistant prolactinomas. Clin Endocrinol (Oxf) 34: 25-29, 1991.
14. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/Cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134: 733-739, 1989.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
16. Gen M, Uozumi T, Ohta M, Ito A, Kajiwara H, Mori S: Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab 59: 463-470, 1984.
17. Gräf KJ, Köhler D, Horowski R, Dorow R: Rapid regression of microprolactinomas by the new dopamine partial agonist terguride. Acta Endocrinol (Copenh) 111: 460-466, 1984.
18. Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JAH, Jones AE, Besser GM: Treatment of prolactinomas with megavoltage radiation therapy. BMJ 288: 1105-1109, 1984.
19. Gudelsky GA, Nansel DD, Porter C: Role of estrogen in the dopaminergic control of prolactin secretion. Endocrinology 108: 440-444, 1981.
20. Hori T, Numata H, Hokama Y, Muraoka K, Saito Y, Kawamoto K: Effects of bromocriptine and radiation on the size and activity of estrogen-induced rat prolactinomas. Neurol Med Chir (Tokyo) 25: 9-14, 1985.
21. Kokunai T, Sawa H, Tamaki N: Localization of apoptotic cells in situ of brain tumors. Noshuyo Byori 12: 15-21, 1995.
22. Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Becker W: Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. Case report. J Neurosurg 82: 886-890, 1995.
23. Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, Lancranjan I, Buchfelder M, Fahlbusch R: Effect of dopamine agonist medication on prolactin producing pituitary adenomas. Virchows Arch [A] 418: 439-446, 1991.
24. Krause W, Dorow B, Nieuweber B, Hasan SH: Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride in man. Eur J Clin Pharmacol 27: 335-339, 1984.
25. Lloyd HM, Meares JD, Jacobi J: Effects of estrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature 255: 479-498, 1975.
26. MacLeod RM, Lehmeyer JE: Studies on the mechanism of the dopamine mediated inhibition of prolactin secretion. Endocrinology 94: 1077-1085, 1974.
27. Mizokawa T, Akai T, Nakada Y, Yamaguchi M, Nakagawa H, Hasan S, Rettig KJ, Wachtel H: Terguride as a new anti-hyperprolactinemic agent: Characterization in rats and dogs in comparison with bromocriptine. Jpn J Pharmacol 63: 269-278, 1993.
28. Oishi Y, Okuda M, Takahashi H, Fujii T, Mori S: Cellular proliferation in the anterior pituitary gland of normal adult rats: Influences of sex, estrous cycle, and circadian change. Anat Rec 235: 111-120, 1993.
29. Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A: Resistance to bromocriptine in prolactinomas. J Clin Endocrinol Metab 69: 500-509, 1989.
30. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Gowney KM, Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-Δ auxiliary protein. Nature 326: 517-520, 1987.
31. Rengachary SR, Tomita T, Jefferies BF, Watanabe I: Structural changes in human pituitary tumor after bromocriptine therapy. Neurosurgery 10: 242-251, 1982.
32. Schran HS, Tse FLS, Bhuta SI: Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. Biopharm Drug Dispos 6: 301-311, 1985.
33. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
34. Thorner MO, Schran HF, Evans WS, Rogol AD, Morris JL, MacLeod RM: A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: A study of serum prolactin and bromocriptine levels after acute and chronic administration of bromocriptine. J Clin Endocrinol Metab 50: 1026-1033, 1980.
35. Tindall GT, Kovacs K, Horvath E, Thorner MO: Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab 55: 1178-1183, 1982.
36. Vance ML, Thorner MO: Prolactinomas. Endocrinol Metab Clin North Am 16: 731-753, 1987.
37. Washio K, Nakashima H, Yanase R, Azuma H: [Pharmacokinetic studies of terguride (1). Absorption, distribution and excretion in rats]. Yakubutsu Dotai 8: 995-1009, 1993 (Jpn, with Eng abstract).
38. Wolfe JM: Morphologic reaction of the anterior pituitaries of mature female rats to prolonged injections of pregnancy urine extracts. Anat Rec 63: 3-11, 1935.
39. Wolfe JM: Cytochemical studies of the anterior hypophyses of rats receiving estrogen. Am J Anat 85: 309-341, 1949.
40. Yanai R, Nagasawa H: Effect of 2-Br-a-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats. Horm Res 5: 1-5, 1974.